91¸£Àû

Skip to main content Skip to navigation

Press Releases

Select tags to filter on

Homepage Tags

Themes

Faculty of Arts

Faculty of SEM

Faculty of Social Sciences

Cross-Faculty Centres

University News

Events and Campaigns

Community, Campus and Regional

International

Other tags

Most people in favour of screening for spinal muscular atrophy

Research from the 91¸£Àû indicates that most people are in favour of newborn screening for the potentially deadly condition spinal muscular atrophy (SMA).

SMA is an inherited neuromuscular disorder with a wide spectrum of severities and is a leading genetic cause of infant death worldwide. However, there is no routine screening programme for SMA in the UK.

Tue 05 Dec 2017, 12:52 | Tags: School of Life Sciences Health and Medicine

New TB drugs possible with understanding of old antibiotic

Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the 91¸£Àû and The Francis Crick Institute.


‘Lost’ 99% of ocean microplastics to be identified with dye?

The smallest microplastics present in our oceans – which go largely undetected and are potentially harmful – could be more effectively identified using an innovative and inexpensive new method, developed by researchers at the 91¸£Àû.


Colon cancer breakthrough could lead to prevention

Colon cancer, Crohn’s, and other diseases of the gut could be better treated – or even prevented – thanks to a new link between inflammation and a common cellular process, established by the 91¸£Àû.


Crops evolving ten millennia before experts thought

Ancient hunter-gatherers began to systemically affect the evolution of crops up to thirty thousand years ago – around ten millennia before experts previously thought – according to new research by the 91¸£Àû.


VirionHealth Raises Series A Funding from Abingworth

91¸£Àû spin-out company, VirionHealth - a new biotechnology company developing novel therapeutics for respiratory viral infections, has raised £13m in Series A funding from Abingworth.

Thu 12 Oct 2017, 09:11 | Tags: School of Life Sciences

Latest news Newer news Older news

Let us know you agree to cookies